Arrowhead Pharmaceuticals, Inc. (LON:0HI3)
London · Delayed Price · Currency is GBP · Price in USD 25.14
+3.37 (15.46%)
At close: Sep 2, 2025
Arrowhead Pharmaceuticals Employees
Arrowhead Pharmaceuticals had 609 employees as of September 30, 2024. The number of employees increased by 84 or 16.00% compared to the previous year.
Employees
609
Change (1Y)
84
Growth (1Y)
16.00%
Revenue / Employee
686.72K GBP
Profits / Employee
-177.88K GBP
Market Cap
2.88B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Sep 30, 2024 | 609 | 84 | 16.00% |
| Sep 30, 2023 | 525 | 128 | 32.24% |
| Sep 30, 2022 | 397 | 68 | 20.67% |
| Sep 30, 2021 | 329 | 97 | 41.81% |
| Sep 30, 2020 | 232 | 98 | 73.13% |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca | 94,300 |
| GSK plc | 68,629 |
| Haleon | 24,561 |
| Smith & Nephew | 17,349 |
| ConvaTec Group | 10,489 |
| Hikma Pharmaceuticals | 9,500 |
| HUTCHMED (China) | 1,811 |
| Oxford Nanopore Technologies | 1,382 |
Arrowhead Pharmaceuticals News
- 3 days ago - Arrowhead Pharma (ARWR): HC Wainwright Maintains Buy Rating | ARWR Stock News - GuruFocus
- 3 days ago - Arrowhead Pharmaceuticals (ARWR) Enters $2.2 Billion Deal with Novartis - GuruFocus
- 3 days ago - Air Lease, Ionis Pharmaceuticals, Arrowhead Pharmaceuticals And Other Big Stocks Moving Higher On Tuesday - Benzinga
- 3 days ago - Arrowhead Pharma Jumps After Inking A Deal Worth Up To $2.2 Billion - Investor's Business Daily
- 3 days ago - Arrowhead Pharmaceuticals and Novartis sign global deal for siRNA therapy - Seeking Alpha
- 3 days ago - Arrowhead and Novartis agree up to $2 billion deal for license to neuromuscular therapy - Reuters
- 3 days ago - Arrowhead Pharmaceuticals and Novartis Enter into a Global License and Collaboration Agreement - Business Wire
- 9 days ago - Arrowhead Pharmaceuticals to Participate in Upcoming September 2025 Conferences - Business Wire